A prostate cancer diagnosis can leave a family with difficult questions: Is the cancer curable? Do I need surgery or radiation? How advanced is it? And where can I get specialist treatment without making the cost of care impossible to manage? For patients from Ghana, Ethiopia, Kenya and Tanzania, India has become an important option for specialist urology and oncology care.
The good news is that prostate cancer treatment is no longer based on one approach for every patient. Doctors can combine modern imaging, pathology, robotic surgery, precision radiation and medicines that work through specific biological pathways. The right treatment depends on the cancer's stage, grade, PSA level, imaging findings, overall health and personal priorities.
Why African Patients Are Looking at India for Prostate Cancer Care
Prostate cancer is a major health concern for men, and delayed diagnosis can make treatment more complex. When specialist services, advanced imaging or particular treatment technologies are difficult to access locally, some patients explore treatment abroad.
India offers a broad combination of urology, medical oncology, radiation oncology, nuclear medicine, pathology and diagnostic services within large hospitals. For an international patient, this can make it possible to have diagnosis, staging and treatment planning coordinated through one medical team.
Choosing India should not be based only on the lowest price or the newest machine. The important questions are whether the hospital has experienced prostate cancer specialists, appropriate diagnostic facilities, multidisciplinary support and a treatment plan suited to the patient's disease.
How Prostate Cancer Is Diagnosed and Staged
Before deciding on prostate cancer treatment, doctors need to understand exactly what they are treating. Evaluation may include a PSA blood test, clinical examination, multiparametric MRI, prostate biopsy and pathology review. The biopsy helps determine the cancer grade, commonly reported using the Gleason score and Grade Group.
For men with higher-risk or suspected metastatic disease, modern staging may include PSMA PET/CT. The 2026 European Association of Urology guidelines recognise PSMA PET/CT as an important staging tool when more accurate assessment of lymph-node or distant disease could affect treatment decisions.
This matters because treatment can change significantly when cancer is found outside the prostate. A patient who appears suitable for surgery after basic tests may need a different combination of treatment if staging shows lymph-node or distant spread.
Prostate Cancer Treatment Options in India
Active Surveillance for Selected Low-Risk Cancer
Not every prostate cancer needs immediate surgery or radiation. For selected men with low-risk and some favourable intermediate-risk disease, active surveillance may be recommended. This means regular PSA testing, clinical review, MRI and, when appropriate, repeat biopsy. The goal is to avoid unnecessary treatment and its possible effects on urinary and sexual function while still treating the cancer if it shows signs of becoming more aggressive.
Robotic Prostate Cancer Surgery
Robotic-assisted radical prostatectomy is one of the advanced surgical options available for appropriately selected prostate cancer patients in India. During the procedure, the surgeon removes the prostate and, when clinically indicated, nearby tissues or lymph nodes using robotic instruments controlled from a surgical console. For appropriately selected patients with localised prostate cancer, robotic surgery can provide precise dissection through small incisions. Potential advantages include less blood loss, shorter hospitalisation and faster physical recovery in many settings. The robot does not perform the operation independently—the surgeon controls it throughout the procedure.
Advanced Radiation Therapy
Radiation therapy is another major treatment option for localised and locally advanced prostate cancer. Techniques such as IMRT, VMAT and image-guided radiation therapy allow specialists to shape and deliver treatment more precisely around the prostate and nearby organs. For selected patients, shorter schedules such as moderate hypofractionation or SBRT may be considered. Brachytherapy is another option for appropriately selected patients.
Hormone Therapy and Newer Systemic Treatments
Prostate cancer can depend on male hormones called androgens to grow. Androgen-deprivation therapy (ADT) reduces or blocks this hormonal stimulation and is commonly used in advanced disease and with radiation for selected higher-risk cancers. Modern treatment also includes newer androgen-receptor pathway medicines, chemotherapy and other systemic approaches. For selected patients, genetic testing can identify changes that may influence targeted treatment, including PARP inhibitors in appropriate clinical settings.
PSMA PET/CT and PSMA-Targeted Treatment
One of the important developments in prostate cancer care is the use of prostate-specific membrane antigen (PSMA) as both an imaging target and, in selected advanced cancers, a treatment target. PSMA PET/CT can help locate prostate cancer in the prostate, lymph nodes or distant sites. For certain patients with metastatic castration-resistant prostate cancer whose tumours show sufficient PSMA expression, radioligand therapy using lutetium-177 PSMA (Lu-177 PSMA) can be considered. It is not suitable for every patient.
Precision Oncology and Molecular Testing
Prostate cancer can behave differently from one patient to another. In advanced or unusual cases, molecular and genetic testing may identify inherited or tumour-specific changes that can influence treatment selection. This supports a more personalised approach, especially when standard options are no longer sufficient.
Can Prostate Cancer Be Cured?
For many men with localised prostate cancer, treatment can be given with curative intent. Surgery or radiation may be used depending on the risk group and the patient's circumstances. Some low-risk cancers can be safely monitored rather than treated immediately.
When prostate cancer has spread to distant organs, the goal is usually long-term disease control rather than a simple one-time cure. Modern combinations of hormone therapy, chemotherapy, targeted medicines, radioligand therapy and other options can provide meaningful control for selected patients.
It is better to discuss expected outcomes in terms of stage, risk group and individual treatment response rather than promising a fixed success rate. No responsible doctor can guarantee a cure based only on a treatment or hospital.
Prostate Cancer Treatment Cost in India
The prostate cancer treatment cost in India varies considerably because there is no single treatment pathway. A patient needing robotic prostatectomy will have a very different cost from a patient requiring radiation, long-term hormone therapy or advanced treatment for metastatic disease.
MUFA MediTourism currently lists an indicative prostate cancer treatment range of USD 5,000 to USD 9,500 on its treatment page. This is a starting indication, not a guaranteed final bill.
The final estimate may depend on diagnostic tests, surgeon and hospital selection, type of treatment, medicines, hospital stay, follow-up and whether additional therapies are required. International patients should request a case-specific estimate after their medical reports have been reviewed.
What African Patients Should Send Before Travelling to India
A medical opinion can often be started before the patient travels. This can save time and help the family understand whether surgery, radiation, systemic therapy or another approach is likely to be appropriate.
- Recent PSA reports and PSA trend, if available
- Prostate biopsy and histopathology report
- Gleason score and Grade Group
- Multiparametric MRI report and images, if available
- PSMA PET/CT, CT, bone scan or other staging reports
- Previous surgery, radiation or medication records
- Current medicines and major medical conditions
- Any previous oncology treatment and response
Patients from Ghana, Ethiopia, Kenya and Tanzania can share available reports with an international patient coordinator so that the appropriate specialist and hospital can be identified before travel.
Why Medical Coordination Matters
Travelling for cancer treatment involves much more than finding a hospital. International patients may need help coordinating specialist appointments, medical documents, treatment estimates, travel planning, accommodation and communication with the hospital.
You can explore MUFA MediTourism's medical tourism services to understand the type of support available for patients travelling to India.
A coordinated process can reduce unnecessary delays and help the patient arrive in India with a clearer treatment pathway.
Questions to Ask Before Choosing Prostate Cancer Treatment in India
- Is my prostate cancer localised, locally advanced or metastatic?
- What is my Gleason score or Grade Group?
- Do I need PSMA PET/CT or another staging scan?
- Am I a candidate for robotic prostate surgery?
- Would radiation therapy be better suited to my case?
- Do I need hormone therapy before or with radiation?
- If the cancer has spread, which systemic treatments are appropriate?
- What is included in the estimated treatment cost?
- How long should I plan to stay in India?
- How will follow-up and PSA monitoring be managed after I return home?
Frequently Asked Questions
What is the best prostate cancer treatment in India?
There is no single best treatment for every patient. Surgery, radiation, active surveillance and medicines may all be appropriate depending on cancer stage, grade, PSA, imaging and overall health.
How much does prostate cancer treatment cost in India?
Costs vary by treatment. MUFA MediTourism currently lists an indicative range of USD 5,000–9,500 on its prostate cancer treatment page, but a personalised estimate is required after medical review.
Is robotic prostate cancer surgery available in India?
Yes. Robotic-assisted radical prostatectomy is available at major Indian hospitals for appropriately selected patients with localised prostate cancer.
What is PSMA PET/CT used for?
PSMA PET/CT can help detect and stage prostate cancer and can be useful when planning treatment or investigating suspected recurrence, particularly in higher-risk or recurrent disease.
Is Lu-177 PSMA therapy suitable for everyone?
No. It is intended for selected patients with advanced prostate cancer whose disease meets the relevant clinical and PSMA-expression criteria. A specialist assessment is essential.
Final Thoughts
For African patients considering prostate cancer treatment in India, the most valuable first step is not choosing a procedure—it is getting the diagnosis and stage reviewed properly. Modern prostate cancer care can combine advanced imaging, robotic surgery, precision radiation, hormone therapy, targeted medicines and PSMA-based treatments when clinically appropriate.
The right plan should be built around the patient's cancer, not around a particular technology. A specialist opinion before travelling can help patients understand their options, expected treatment duration and likely costs before making a major medical and travel decision.
If you would like to discuss treatment planning in India, contact MUFA MediTourism to share your medical details and discuss the next steps.
Medical Disclaimer
This article is for general educational purposes and does not replace advice from a qualified urologist, radiation oncologist or medical oncologist. Treatment decisions must be individualised based on pathology, stage, imaging, biomarkers, medical history and overall health. Treatment availability, medicine approvals and prices may change.